Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
TRICARE began covering Wegovy for obesity in 2021, provided the patient meets very specific clinical criteria
GLP-1 medications can be valuable tools for some patients, but they are not a stand-alone solution
The company is limiting how much of the starting dose of Wegovy it produces to focus on supplying the drug to patients already on it and who work their way up to higher doses for continuing treatment
In other business news, Kuehnle AgroSystems secured multi-million-dollar Series B funding to commercially scale its natural astaxanthin dark fermentation technology
It helps regulate blood sugar, slows down how fast your stomach empties, and reduces appetite by acting on hunger signals in your brain
